Skip to main content
PharmSpace

SNRIs · Psychiatry

Venlafaxine

Effexor XR®(brand names vary by market)

An SNRI that is mostly an SSRI at low dose and finds its noradrenaline at higher doses.

Illustration of Venlafaxine as a modified releaseVEN

Also: capsule

Mechanism

Serotonin and (dose-dependently) noradrenaline reuptake inhibition; the dual mechanism arrives as the dose climbs.

Open the interactive pathway

Indications

  • Major depressive disorder
  • Generalized anxiety disorder
  • Panic disorder

Formulations

Modified releaseCapsule

Dosing concepts

Blood pressure

Noradrenergic activity raises blood pressure dose-dependently; check it before and after titration.

Discontinuation

Short half-life makes venlafaxine's discontinuation syndrome among the worst of the antidepressants; taper slowly and never end on alternate-day dosing of the XR form.

Concepts, not prescribing instructions. Practice numbers live in current references and local protocols.

Pharmacokinetics

Bioavailability
~45%
Half-life
5 h (parent), 11 h (active metabolite)
Elimination
hepatic: CYP2D6 to the equally active desvenlafaxine
Play with these concepts in the PK Lab

Adverse effects

  • Nausea (early)common
  • Hypertension, dose-relatedcommon & serious
  • Sweating, insomniacommon
  • Discontinuation syndromecommon
  • Serotonin syndrome with serotonergic partnersserious

Contraindications & precautions

Contraindications

  • MAO inhibitor within 14 days

Precautions

  • Uncontrolled hypertension
  • Arrhythmia history

Interactions

Monitoring

Blood pressure

The class-defining check SSRIs do not need · Baseline and after dose increases

Mood and safety

Effectiveness

Counselling points

  • Take the XR capsule once daily with food.
  • Missed doses can cause dizziness and 'zaps' within a day or two. Consistency matters more than with most medications.

Clinical pearls

  • If a patient reports withdrawal symptoms the same evening a dose is missed, think venlafaxine before anything else.

References & review

  • Venlafaxine product monograph (consult the current version for your market) (monograph)
  • Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed. (reference-work)

Last reviewed 2026-08-15 · jurisdiction: global · drug information changes; verify against current references before practice use.